Pregled bibliografske jedinice broj: 76344
Genotyping of MTHFR and Apo E, homocysteine levels and cardiovascular disease
Genotyping of MTHFR and Apo E, homocysteine levels and cardiovascular disease // 1st Croatian Congress of Molecular Life Sciences, Book of abstracts / Dumić, Jerka et al. (ur.).
Zagreb: Farmaceutsko-biokemijski fakultet Sveučilišta u Zagrebu, 2002. (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 76344 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Genotyping of MTHFR and Apo E, homocysteine levels and cardiovascular disease
Autori
Žuntar, Irena ; Topić, Elizabeta ; Vrkić, Nada ; Antoljak, Nataša ; Vukosavić, Đuro ; Kujundžić, Nikola
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
1st Croatian Congress of Molecular Life Sciences, Book of abstracts
/ Dumić, Jerka et al. - Zagreb : Farmaceutsko-biokemijski fakultet Sveučilišta u Zagrebu, 2002
Skup
1st Croatian Congress of Molecular Life Sciences with international participation
Mjesto i datum
Opatija, Hrvatska, 09.06.2002. - 13.06.2002
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
MTHFR; Apo E; homocysteine; cardiovascular disease
Sažetak
Atherosclerosis is most common arterial disease and the leading cause of cardiac disease (CAD). One of the candidate genes for the genesis of atherosclerosis is apolipoprotein E (apo E), with a recently identified indicator, methylenetetrahydrololate reductase (MTHFR). MTHFR is one of the major regulatory enzymes in the metabolism or homocysteine (Hcy), a recently identified risk factor for atherosclerosis. The aim of the study is to evaluate importance of genetic (apo E and MTHFR) and biochemical (Hcy) markers in patients with CAD. Genotypes were determined by PCR-RFLP method and Hcy level by EIA in samples of healthy controls (n=60) and angiographically-confirmed patients with CAD (, n=33). In CAD group a significant different apo E genotype (p<0.05), but no significant difference in MTHFR genotype distribution compared to the control was found. In the group of patients and controls no TT genotype was found. The odds ratio for heterozygous apo E 3/4 genotype was 4.13 (95% CI 1.25-13.61). No significant difference of Hcy leveles (p>0.05) was found. Hyperhomocysteinemia (>15 ÝM) was determined in 5% of controls and 7% of patients. Association of MTHFR with apo E genotype as well as MTHFR genotype and Hcy level was not found. The preliminary results obtained in this study revealed an association of apo E, but no MTHFR genotype and Hcy level with CAD. Additional studies in larger patient groups are needed to confirm these observations.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Nikola Kujundžić
(autor)
Nada Vrkić
(autor)
Irena Žuntar
(autor)
Nataša Antoljak
(autor)
Đuro Vukosavić
(autor)
Elizabeta Topić
(autor)